Does the oxysterol 27-hydroxycholesterol underlie Alzheimer's disease-Parkinson's disease overlap?

Experimental Gerontology

Volumn 68, Issue , 2015, Pages 13-18

  Marwarha, Gurdeep ^a   Ghribi, Othman ^a  

^a UNIVERSITY OF NORTH DAKOTA SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

Author keywords

Alpha synuclein; Alzheimer's disease; Endoplasmic reticulum stress; Oxysterols; Parkinson's disease

Indexed keywords

26 HYDROXYCHOLESTEROL; ALPHA SYNUCLEIN; CHOLESTEROL; OXYSTEROL; OXYSTEROL 26 HYDROXYCHOLESTEROL; UNCLASSIFIED DRUG; 27-HYDROXYCHOLESTEROL; CHOLESTEROL DERIVATIVE; CHOLESTEROL INTAKE; LIVER X RECEPTOR; ORPHAN NUCLEAR RECEPTOR;

ALZHEIMER DISEASE; BLOOD LEVEL; BRAIN LEVEL; CHOLESTEROL METABOLISM; DISEASE ACTIVITY; DISEASE ASSOCIATION; HUMAN; LIPID HOMEOSTASIS; MOLECULAR DYNAMICS; MOLECULAR PATHOLOGY; NONHUMAN; OXIDATION; PARKINSON DISEASE; PRIORITY JOURNAL; REVIEW; TARGET CELL; AMYLOID PLAQUE; ANIMAL; BLOOD; BRAIN; CHOLESTEROL INTAKE; DISEASE MODEL; ENDOPLASMIC RETICULUM STRESS; HOMEOSTASIS; LIPID METABOLISM; METABOLISM; PHARMACOLOGY; PHYSIOLOGY; RABBIT;

ALPHA-SYNUCLEIN; ALZHEIMER DISEASE; ANIMALS; BRAIN; CHOLESTEROL, DIETARY; DISEASE MODELS, ANIMAL; ENDOPLASMIC RETICULUM STRESS; HOMEOSTASIS; HUMANS; HYDROXYCHOLESTEROLS; LIPID METABOLISM; LIVER X RECEPTORS; ORPHAN NUCLEAR RECEPTORS; PARKINSON DISEASE; PLAQUE, AMYLOID; RABBITS;

EID: 84941313899     PISSN: 05315565     EISSN: 18736815     Source Type: Journal    
DOI: 10.1016/j.exger.2014.09.013     Document Type: Review

References (47)

1. Bazan N.G., Molina M.F., Gordon W.C. Docosahexaenoic acid signalolipidomics in nutrition: significance in aging, neuroinflammation, macular degeneration, Alzheimer's, and other neurodegenerative diseases. Annu. Rev. Nutr. 2011, 31:321-351.
2. Bjorkhem I., Meaney S., Diczfalusy U. Oxysterols in human circulation: which role do they have?. Curr. Opin. Lipidol. 2002, 13:247-253.
3. Bosco D.A., Fowler D.M., Zhang Q., Nieva J., Powers E.T., Wentworth P., Lerner R.A., Kelly J.W. Elevated levels of oxidized cholesterol metabolites in Lewy body disease brains accelerate alpha-synuclein fibrilization. Nat. Chem. Biol. 2006, 5:249-253.
4. Brown A.J., Jessup W. Oxysterols and atherosclerosis. Atherosclerosis 1999, 142:1-28.
5. Brown J., Theisler C., Silberman S., Magnuson D., Gottardi-Littell N., Lee J.M., Yager D., Crowley J., Sambamurti K., Rahman M.M., Reiss A.B., Eckman C.B., Wolozin B. Differential expression of cholesterol hydroxylases in Alzheimer's disease. J. Biol. Chem. 2004, 279:34674-34681.
6. Chen X., Gawryluk J.W., Wagener J.F., Ghribi O., Geiger J.D. Caffeine blocks disruption of blood brain barrier in a rabbit model of Alzheimer's disease. J. Neuroinflammation 2008, 5:12. (Apr 3).
7. Cheng D., Kim W.S., Garner B. Regulation of alpha-synuclein expression by liver X receptor ligands in vitro. Neuroreport 2008, 19:1685-1689.
8. Cheng D., Jenner A.M., Shui G., Cheong W.F., Mitchell T.W., Nealon J.R., Kim W.S., McCann H., Wenk M.R., Halliday G.M., Garner B. Lipid pathway alterations in Parkinson's disease primary visual cortex. PLoS One 2011, 6:e17299.
9. Choi S.H., Olabarrieta M., Lopez O.L., Maruca V., Dekosky S.T., Hamilton R.L., Becker J.T. Gray matter atrophy associated with extrapyramidal signs in the Lewy bodyvariant of Alzheimer's disease. J. Alzheimers Dis. 2012, 32(4):1043-1049.
10. Corder E.H., Saunders A.M., Strittmatter W.J., Schmechel D.E., Gaskell P.C., Small G.W., Roses A.D., Haines J.L., Pericak-Vance M.A. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 1993, 261:921-923.
11. de Lau L.M., Bornebroek M., Witteman J.C., Hofman A., Koudstaal P.J., Breteler M.M. Dietary fatty acids and the risk of Parkinson disease: the Rotterdam study. Neurology 2005, 64:2040-2045.
12. Eto M., Watanabe K., Chonan N., Ishii K. Familial hypercholesterolemia and apolipoprotein E4. Atherosclerosis 1988, 72(2-3):123-128. (Aug).
13. Ghribi O., Golovko M.Y., Larsen B., Schrag M., Murphy E.J. Deposition of iron and beta-amyloid plaques is associated with cortical cellular damage in rabbits fed with long-term cholesterol-enriched diets. J. Neurochem. 2006, 99(2):438-449.
14. Ghribi O., Larsen B., Schrag M., Herman M.M. High cholesterol content in neurons increases BACE, beta-amyloid, and phosphorylated tau levels in rabbit hippocampus. Exp. Neurol. 2006, 200(2):460-467.
15. Graur D., Duret L., Gouy M. Phylogenetic position of the order Lagomorpha (rabbits, hares and allies). Nature 1999, 379:333-335.
16. Heverin M., Bogdanovic N., Lütjohann D., Bayer T., Pikuleva I., Bretillon L., Diczfalusy U., Winblad B., Björkhem I. Changes in the levels of cerebral and extracerebral sterols in the brain of patients with Alzheimer's disease. J. Lipid Res. 2004, 445(1):186-193.
17. Heverin M., Meaney S., Lutjohann D., Diczfalusy U., Wahren J., Bjorkhem I. Crossing the barrier: net flux of 27-hydroxycholesterol into the human brain. J. Lipid Res. 2005, 46(5):1047-1052.
18. Hu G. Total cholesterol and the risk of Parkinson's disease: a review for some new findings. Park. Dis. 2010, 2010:836962.
19. Hu G., Antikainen R., Jousilahti P., Kivipelto M., Tuomilehto J. Total cholesterol and the risk of Parkinson disease. Neurology 2008, 70(21):1972-1979. (May 20).
20. Huang X., Auinger P., Eberly S., Oakes D., Schwarzschild M., Ascherio A., Mailman R., Chen H. Parkinson Study Group DATATOP Investigators. Serum cholesterol and the progression of Parkinson's disease: results from DATATOP. PLoS One 2011, 6(8):e22854.
21. Infante J., Rodríguez-Rodríguez E., Mateo I., Llorca J., Vázquez-Higuera J.L., Berciano J., Combarros O. Gene-gene interaction between heme oxygenase-1 and liver X receptor-beta and Alzheimer's disease risk. Neurobiol. Aging 2010, 31(4):710-714. (Apr).
22. Janowski B.A., Willy P.J., Devi T.R., Falck J.R., Mangelsdorf D.J. An oxysterol signalling pathway mediated by the nuclear receptor LXR alpha. Nature 1996, 383:728-731.
23. Johnson C.C., Gorell J.M., Rybicki B.A., Sanders K., Peterson E.L. Adult nutrient intake as a risk factor for Parkinson's disease. Int. J. Epidemiol. 1999, 28:1102-1109.
24. Johnstone E.M., Chaney M.O., Norris F.H., Pascual R., Little S.P. Conservation of the sequence of the Alzheimer's disease amyloid peptide in dog, polar bear and five other mammals by cross-species polymerase chain reaction analysis. Brain Res. Mol. Brain Res. 1999, 10:299-305.
25. Kotzbauer P.T., Trojanowsk J.Q., Lee V.M. Lewy body pathology in Alzheimer's disease. J. Mol. Neurosci. 2001, 17(2):225-232. (Oct).
26. Lange Y., Ye J., Rigney M., Steck T.L. Regulation of endoplasmic reticulum cholesterol by plasma membrane cholesterol. J. Lipid Res. 1999, 40:2264-2270.
27. Lutjohann D., Breuer O., Ahlborg G., Nennesmo I., Siden A., Diczfalusy U., Bjorkhem I. Cholesterol homeostasis in human brain: evidence for an age-dependent flux of 24S-hydroxycholesterol from the brain into the circulation. Proc. Natl. Acad. Sci. U.S.A. 1996, 93:9799-9804.
28. Lutjohann D., Papassotiropoulos A., Bjorkhem I., Locatelli S., Bagli M., Oehring R.D., Schlegel U., Jessen F., Rao M.L., von B.K., Heun R. Plasma 24S-hydroxycholesterol (cerebrosterol) is increased in Alzheimer and vascular demented patients. J. Lipid Res. 2000, 41:195-198.
29. Mapstone M., Cheema A.K., Fiandaca M.S., Zhong X., Mhyre T.R., MacArthur L.H., Hall W.J., Fisher S.G., Peterson D.R., Haley J.M., Nazar M.D., Rich S.A., Berlau D.J., Peltz C.B., Tan M.T., Kawas C.H., Federoff H.J. Plasma phospholipids identify antecedent memory impairment in older adults. Nat. Med. 2014, 20(4):415-418. (Apr).
30. Marwarha G., Dasari B., Prasanthi J.R.P., Schommer J., Ghribi O. Leptin is involved in accumulation of amyloid-beta and tau phosphorylation induced by 27-hydroxycholesterol in organotypic slices from adult rabbit hippocampus. J. Alzheimers Dis. 2010, 19(3):1007-1019.
31. Marwarha G., Rhen T., Schommer T., Ghribi O. The oxysterol 27-hydroxycholesterol regulates α-synuclein and tyrosine hydroxylase expression levels in human neuroblastoma cells through modulation of liver X receptors and estrogen receptors - relevance to Parkinson's disease. J. Neurochem. 2011, 119(5):1119-1136. (Dec).
32. Marwarha G., Dasari B., Ghribi O. Endoplasmic reticulum stress-induced CHOP activation mediates the down-regulation of leptin in human neuroblastoma SH-SY5Y cells treated with the oxysterol 27-hydroxycholesterol. Cell. Signal. 2012, 24(2):484-492. (Feb).
33. Marwarha G., Raza S., Prasanthi J.R., Ghribi O. Gadd153 and NF-κB crosstalk regulates 27-hydroxycholesterol-induced increase in BACE1 and β-amyloid production in human neuroblastoma SH-SY5Y cells. PLoS One 2013, 8(8):e70773. (Aug 9).
34. Powers K.M., Smith-Weller T., Franklin G.M., Longstreth W.T., Swanson P.D., Checkoway H. Dietary fats, cholesterol and iron as risk factors for Parkinson's disease. Parkinsonism Relat. Disord. 2009, 15:47-52.
35. Prasanthi J.R.P., Huls A., Thomasson S., Thompson A., Schommer E., Ghribi O. Differential effects of 24-hydroxycholesterol and 27-hydroxycholesterol on beta-amyloid precursor protein levels and processing in human neuroblastoma SH-SY5Y cells. Mol. Neurodegener. 2009, 4:1.
36. Raffai R.L., Weisgraber K.H. Cholesterol: from heart attacks to Alzheimer's disease. J. Lipid Res. 2003, 44(8):1423-1430. (Aug).
37. Rantham Prabhakara J.P., Feist G., Thomasson S., Thompson A., Schommer E., Ghribi O. Differential effects of 24-hydroxycholesterol and 27-hydroxycholesterol on tyrosine hydroxylase and alpha-synuclein in human neuroblastoma SH-SY5Y cells. J. Neurochem. 2008, 107:1722-1729.
38. Reed B., Villeneuve S., Mack W., DeCarli C., Chui H.C., Jagust W. Associations between serum cholesterol levels and cerebral amyloidosis. JAMA Neurol. 2014, 71(2):195-200. (Feb).
39. Refolo L.M., Malester B., LaFrancois J., Bryant-Thomas T., Wang R., Tint G.S., Sambamurti K., Duff K., Pappolla M.A. Hypercholesterolemia accelerates the Alzheimer's amyloid pathology in a transgenic mouse model. Neurobiol. Dis. 2000, 7(4):321-331. (Aug).
40. Reitz C., Tang M.X., Schupf N., Manly J.J., Mayeux R., Luchsinger J.A. Association of higher levels of high-density lipoprotein cholesterol in elderly individuals and lower risk of late-onset Alzheimer disease. Arch. Neurol. 2010, 67(12):1491-1497. (Dec).
41. Schrag M., Sharma S., Brown-Borg H., Ghribi O. Hippocampus of Ames dwarf mice is resistant to beta-amyloid-induced tau hyperphosphorylation and changes in apoptosis-regulatory protein levels. Hippocampus 2008, 18(3):239-244.
42. Schreurs B.G., Wang D., Smith-Bell C.A., Burhans L.B., Bell R., Gonzalez-Joekes J. Dietary cholesterol concentration and duration degrade long-term memory of classical conditioning of the rabbit's nictitating membrane response. Int. J. Alzheimers Dis. 2012, 2012:732634.
43. Sharma S., Prasanthi R.P.J., Schommer E., Feist G., Ghribi O. Hypercholesterolemia-induced Abeta accumulation in rabbit brain is associated with alteration in IGF-1 signaling. Neurobiol. Dis. 2008, 32(3):426-432. (Dec).
44. Solomon A., Kivipelto M., Wolozin B., Zhou J., Whitmer R.A. Midlife serum cholesterol and increased risk of Alzheimer's and vascular dementia three decades later. Dement. Geriatr. Cogn. Disord. 2009, 28:75-80.
45. Sparks D.L., Scheff S.W., Hunsaker J.C., Liu H., Landers T., Gross D.R. Induction of Alzheimer-like beta-amyloid immunoreactivity in the brains of rabbits with dietary cholesterol. Exp. Neurol. 1994, 126:88-94.
46. Vaya J., Song W., Khatib S., Geng G., Schipper H.M. Effects of heme oxygenase-1 expression on sterol homeostasis in rat astroglia. Free Radic. Biol. Med. 2007, 42(6):864-871. (Mar 15).
47. Woodruff-Pak D.S., Seta S.E., Roker L.A., Lehr M.A. Effects of paradigm and inter-stimulus interval on age differences in eyeblink classical conditioning in rabbits. Learn. Mem. 2007, 14(4):287-294. (Apr 6).